Industry stakeholders have expressed their willingness to cooperate with the FDA in its effort to reduce exposure to medical radiation from imaging tests. However, some groups say they wonder whether the agency's proposed measures would be workable in light of speedy technology adoption and regulatory constraints. Imaging device makers question whether the suggested built-in equipment warning system would be effective at preventing unnecessary radiation exposure, and accreditation groups still don't know whether the initiative would require changes in their accreditation procedures.

Related Summaries